All Type of News
‘2 Strong’ system in entecavir market, led by Dong-A and Bukwang
In the market of entecavir(product name: Baraclude), one of the last year’s largest issues in the patent expiration field, Dong-A ST and Bukwang Pharm have formed a 2-stong competition.
For the 3rd position, Hanmi P...
Pharmaceutical companies look glamorous outside, but polarization was intensified
It was analyzed pharmaceutical companies made glamorous profits, but the polarization of wealth among them was intensified last year.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 2015 audit rep...
Celltrion, “Janssen’s Remsima patent infringement lawsuit is unreasonable”When it comes to the Janssen’s Remsima patent infringement lawsuit(request to accelerate screening), Celltrion argued the US7,598,083 is a patent related to a badge containing t...
|
President Park to promote and support biopharmaceutical industry
In order to nurture the biopharmaceutical industry, the government will powerfully revise restrictions. Using the action, its goal is to increase its market share in the global market by 5% by the year of 2025 as prom...
Pharmacies shocked by move to ease regulation for foreign pharmaceutical purchases
Since a move to ease the current Pharmaceutical Affairs Law to restrict direct purchases of pharmaceutical products in a foreign country by an individual has been visualized, the pharmacy world is expected to strongly...
Korean doctors have 3-times higher cancer occurrence
Generally, medical doctors are thought to be healthier than others because they have a wider range of medical knowledge. However, according to a U.S. research, medical doctors who tend to work late were observed to ha...
High cost/sales rate leads to low profitability for multinational pharmaceuticals
Multinational pharmaceutical companies were observed to have low profitability due to high cost/sales rates.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 2015 audit reports of 32 multinational ...
Insurance benefits will be applied for Sovaldi and Harvoni this May
While a group infection of hepatitis C has recently been controversial, new hepatitis C treatments will be applied by the health insurance benefit from this May.
Through the Amendment to the ‘Drug Benefit List and C...
Ups and downs in prescription drug ranking
This first quarter’s ranking of prescription drugs was fluctuated due to patent expirations of original products.
Positions of Baraclude(BMS) and Celebrex(Pfizer) dropped due to their price cuts caused by the last y...
Performance of each pharmaceutical company competing for joint promotion
A rare atmosphere was recently formed among domestic pharmaceutical companies which compete over introduction of blockbuster products.
In this process, a number of products were switched for companies to jointly prom...
